Case-Based Roundtable
General Dermatology
Eczema
Chronic Hand Eczema
Chronic Spontaneous Urticaria
Alopecia
Aesthetics
Vitiligo
COVID-19
Actinic Keratosis
Precision Medicine and Biologics
Rare Disease
Wound Care
Rosacea
Psoriasis
Psoriatic Arthritis
Atopic Dermatitis
Melasma
NP and PA
Skin Cancer
Hidradenitis Suppurativa
Drug Watch
Pigmentary Disorders
Acne
Pediatric Dermatology
Practice Management
Prurigo Nodularis
Buy-and-Bill

Video

December 13, 2022

Future Directions and Practice Pearls for the Management of Acne

Author(s):

Hilary Baldwin, M.D., shares her hopes for the future of acne treatment and provides her practice pearls from a panel discussion surrounding the management of patients suffering from acne.

EP: 1.Expert Perspectives on a Recent Approval in Acne Management

EP: 2.Treatment Selection Considerations for Mild to Moderate Acne

EP: 3.Unmet Needs and the Role of Consensus Guidelines in Acne Management

Now Viewing

EP: 4.Future Directions and Practice Pearls for the Management of Acne

EP: 5.Expert Perspective on Tailoring Acne Treatments

EP: 6.Skin Care Regimens for Acne Treatment

EP: 7.Acne Treatment Selection Considerations

EP: 8.Overview of Isotretinoin Use and Indication in Acne Management

EP: 9.Expert Perspective on Available Isotretinoin Formulations

EP: 10.Expert Recommendations for Setting and Managing Acne Treatment Goals with Patients

EP: 11.Overview of Acne Causes and Triggers

EP: 12.Considerations for Generic vs Brand Acne Treatment Formulations

EP: 13.Expert Perspectives on Acne Causes and Triggers

EP: 14.Overview of Isotretinoin MOA and Utilization

EP: 15.Frontline Forum Part 1: A Discussion of the Pathophysiology of Acne and Available Treatment Strategies

EP: 16.Frontline Forum Part 2: A Discussion of the Pathophysiology of Acne and Available Treatment Strategies

EP: 17.Frontline Forum Part 3: A Discussion of the Pathophysiology of Acne and Available Treatment Strategies

EP: 18.Frontline Forum Part 4: A Discussion of the Pathophysiology of Acne and Available Treatment Strategies

EP: 19.Expert Perspective on the Management of Acne

EP: 20.Treatment Selection in Patients with Acne Vulgaris

EP: 21.Differences in Isotretinoin Formulation

EP: 22.Expert Perspective on the Utilization of Clascoterone Cream 1%

EP: 23.Utilization of Isotretinoin in Patients with Severe Acne

EP: 24.Expert Insights into the Safety of Isotretinoin

EP: 25.Overview and Prevalence of Acne Vulgaris

EP: 26.Approaches to Target Sebum Production

EP: 27.Expert Insights into the Use of Isotretinoin

EP: 28.Advances in Acne Management

EP: 29.Expert Opinion on the Utility of Guidelines in Patient Care

EP: 30.Novel Approach to Sebum Production

EP: 31.Expert Insights into the Importance of Active Components in Acne Treatments

EP: 32.Frontline Forum Part 1: A Greater Understanding of the Acne Vulgaris Armamentarium

EP: 33.Frontline Forum Part 2: A Greater Understanding of the Acne Vulgaris Armamentarium

EP: 34.Frontline Forum Part 3: A Greater Understanding of the Acne Vulgaris Armamentarium

EP: 35.Frontline Forum Part 4: A Greater Understanding of the Acne Vulgaris Armamentarium

EP: 36.Discovering Dermatology Times: August 2023 Acne Vulgaris Supplement

EP: 37.Top 5 Clinical Pearls for Acne Vulgaris Management

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Subscribe Now!